Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
7.31
+0.01 (0.14%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Arvinas Market Cap
Arvinas has a market cap or net worth of $477.97 million as of October 26, 2026. It is the 14,809th most valuable company in the world and the 2,764th biggest in the United States. Its market cap has decreased by 29.31% in one year.
Market Cap
477.97M
Enterprise Value
-81.93M
1-Year Change
-29.31%
Global Rank
Country Rank
#2,764 United States
Category
ChartMarket Cap Chart
Since September 27, 2018, Arvinas's market cap has decreased from $500.50M to $477.97M, a decrease of -4.50%. That is a compound annual growth rate of -0.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 477.97M | -37.25% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -41.84% |
| Dec 29, 2023 | 2.26B | 24.38% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 26.11% |
| Dec 31, 2020 | 3.44B | 148.34% |
| Dec 31, 2019 | 1.39B | 233.58% |
| Dec 31, 2018 | 415.70M | -16.94% |
| Sep 27, 2018 | 500.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 506.01M |
| Bright Minds Biosciences | 502.98M |
| Entera Bio | 497.42M |
| Oculis Holding AG | 491.39M |
| CytomX Therapeutics | 484.83M |
| Surrozen | 477.27M |
| Monopar Therapeutics | 473.48M |
| Phathom Pharmaceuticals | 471.81M |